All the Latest Game Footage and Images from High School DxD Highschool DxD is a visual novel from Kadokawa Games, based on the events of the first season of the anime. Games metadata is powered by ...

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...

What comes after trastuzumab deruxtecan?

The first half of 2026 is already coming to a close. How is everyone doing? First, I would like to talk about a hot topic. On May 15th, we held the DXD Camp Special Forum at YANMAR TOKYO. We had many ...

The FDA has approved trastuzumab deruxtecan (T-DXd; Enhertu, Daiichi Sankyo/AstraZeneca) in combination with pertuzumab for the first-line treatment of unresectable or metastatic HER2-positive breast ...

R-DXd targets CDH6 in platinum-resistant ovarian, primary peritoneal, or fallopian tube cancers, showing a 46% objective response rate in a phase 1 trial. FDA breakthrough therapy designation aims to ...

Ifinatamab deruxtecan targets B7-H3 and is a potential first-in-class antibody-drug conjugate for extensive-stage small cell lung cancer. The FDA's Breakthrough Therapy Designation aims to expedite ...

When Merck & Co. and Daiichi Sankyo last year received an FDA complete response letter for their HER3-directed antibody-drug conjugate (ADC) patritumab deruxtecan, the companies hoped to address ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...